Network News

AGC Biologics’ Heidelberg Site Supplies Drug Substance for Phase II Studies of Valneva’s Tetravalent Shigella Vaccine Candidate

SEATTLE AND HEIDELBERG – July 29, 2025 – AGC Biologics, your friendly CDMO expert, today announced a development and manufacturing services agreement with specialty vaccine company Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) to supply drug substance for an investigational four-valent Shigella bioconjugate vaccine at the CDMO’s Heidelberg facility. Valneva exclusively licensed the vaccine candidate from LimmaTech Biologics AG, which […]

From bench to code: collaboration unlocks insights into Alzheimer’s disease

How a chance encounter at a scientific conference resulted in a fruitful cross-Atlantic research collaboration In 2023, EMBL-EBI Postdoctoral Fellow Iguaracy Pinheiro de Sousa presented his bioinformatics work on how cells communicate within the heart, as part of the Network Biology meeting in Cold Spring Harbour, New York. “I met Yifei Cai during the opening […]

Beyond 1000 genomes: going deeper and wider

Ten years after the end of the 1000 Genomes Project, brand new insights emerge from its sample set, providing a more complete view of human genetic variation than ever before Summary Completed in 2003, the Human Genome Project gave us the first sequence of the human genome, albeit based on DNA from a small handful […]

NADHJA – Development of a miniaturized measurement system for non-invasive detection of the acute individual metabolic state using artificial intelligence

Lactate diagnostics is particularly important in sports medicine performance diagnostics and has been carried out conventionally for almost 100 years using blood samples and laboratory analyses. This project aims to develop a measurement method and functional model of a mobile device based on the NADHJA analyzer from mfd Diagnostics GmbH, which uses a fluorescence-optical method […]

Launching BioLabs | TUM: Where science powers startups

Munich, Germany – BioLabs, TUM Venture Labs, and Eli Lilly and Company (Lilly) today launched BioLabs|TUM, a new biotechnology innovation hub in central Munich. The initiative aims to empower early-stage biotech startups by providing access to state-of-the-art lab infrastructure, expert mentoring, and global industry networks. Located in a refurbished 1,800-square-meter facility, BioLabs|TUM will offer fully […]

New Research Unit in Basic Biomedical Research

German Research Foundation provides approx. five million euros in funding Heidelberg University has been successful in the most recent funding round of the German Research Foundation (DFG) with its proposal for a new DFG Research Unit in basic biomedical research. As part of this collaborative project, researchers are investigating the fundamental principles that enable organisms […]

The origin of evil: stem cell-like cells are the reason for relapses of blood cancer in children and adolescents

Stem cell-like leukemia cells are responsible for relapses in children and adolescents with a certain type of blood cancer, T-ALL. Researchers at the Hopp Children’s Cancer Center Heidelberg (KiTZ), the Molecular Medicine Partnership Unit (MMPU) – an inter-institutional partnership between the European Molecular Biology Laboratory (EMBL) and the Medical Faculty of Heidelberg University – and […]

Colorectal cancer in type 2 diabetes: An insightful look into the microenvironment of tumors

Diabetics have a higher risk of colorectal cancer and often a poorer prognosis after developing the disease. The biological mechanisms behind this association were largely unknown. A research team at the German Cancer Research Center (DKFZ) has now discovered that tumors with a low number of immune cells appear to be particularly susceptible to the […]

Faster sepsis diagnosis through hyperspectral imaging and AI

Sepsis is one of the most dangerous medical emergencies. The condition is the result of a misdirected immune response to an infection, which can quickly lead to organ failure and death. Every hour counts – but early detection is difficult in clinical practice. A new study from Heidelberg now presents an innovative approach: artificial intelligence […]